Current status:
Cancelled Post Market
Current status date:
2009-01-23
DIN:
02245951
Electronic product monograph is not available
Company:
WYETH CANADA
1025 Boulevard Marcel Laurin
St. Laurent
Quebec
Canada
H4R 1J6
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Anatomical Therapeutic Chemical (ATC):
See footnote 4
B02BD02 COAGULATION FACTOR VIII
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
MOROCTOCOG ALFA
|
1000 UNIT / VIAL
|